2th Annual Course of Academy of Immunohistochemistry
Diagnostic Immunohistochemistry and Molecular Pathology

Kraków, Poland, 12-13th October 2015


Prof. Lars Egevad

(Sweden): Professor of Pathology at Karolinska Institutet, Stockholm, Sweden. His main interest is pathology of the prostate. He is involved in many international organizations, meetings and committees including presidency of International Society of Urological Pathology and European Network of Uropathology. He has authored more than 230 publications mainly in urological pathology including co-authorship of WHO Classification of Tumors of the Urinary System and Male Genital Organs 3rd edition. In 2008 awarded with The Koss medal for his contributions to urological pathology.

Prof. Jerzy Lasota (USA)

Staff Scientist at the Surgical Pathology Section of the Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland. Previously at the Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington, D.C., Thomas Jefferson University and Temple University’s Fels Institute for Cancer Research and Molecular Biology in Philadelphia, as a Research Pathologist and in the Molecular Diagnostic Laboratory. He is an author and co-author of 130 publications, including studies on genotyping gastrointestinal stromal tumours and several book chapters on molecular genetics of soft tissue tumors.

Prof. Markku Miettinen (USA)

Professor and Head of Surgical Pathology, National Cancer Institute, Bethesda, Maryland, previously at Armed Forces Institute of Pathology, Washington DC and Thomas Jefferson University, Philadelphia, USA. His main interest is pathology of soft tissues. His contribution to definition, biology and diagnosis of Gastrointestinal Stromal Tumors is well recognized. He is a member of editorial boards in several top ranked pathology journals and reviewer in a number of most recognized pathology journals. His list of publications has more than 350 positions including two handbooks on Pathology of Soft Tissues and contributions to WHO Classification of Tumours of Soft Tissue and Bone. In recognition of his work honored with Totten Lecture and Award, University of Pittsburgh in 2005.

Prof. Mogens Vyberg (Denmark)

Professor of Clinical Pathology at Aalborg University, Senior Consultant and the Head of the Laboratory of Immunohistochemistry at the Institute of Pathology, Aalborg University Hospital, Denmark. His main research fields and expertise are immunohistochemistry and gastrointestinal, liver and brain pathology. He is author and co-author of more than 75 scientific papers and several book chapters in these fields as well as the text book Compendium of Applied Immunohistochemistry (Danish; English version scheduled for 2015). He is also a co-founder and scheme director of the Nordic Immunohistochemical Quality Control (NordiQC).

Jan Klos MD (Norway)

Senior Consultant and a Head of the Immunohistochemistry Section in the Department of Pathology, Stavanger University Hospital, Norway.  His professional focus is on diagnostic pathology and particularly hematopathology, pathology of the breast and cytopathology.  He has been actively involved in teaching immunohistochemistry since 2000 as co-organizer of national and international meetings and as invited lecturer. Since 2009 he is a member of the core group and assessor in NordiQC organization. He is a co-author of more than 30 publications in pathology.

Søren Nielsen HT (Denmark)

Senior Histotechnologist and project coordinator at Institute of Pathology, Aalborg Hospital, Denmark. He has been involved within immunohistochemistry for more than 20 years. He is the scheme manager of Nordic immunohistochemical Quality Control (NordiQC) from the beginning of the organization. He is also an assessor and data analyst in the NordiQC general module, breast module and HER-2 ISH module as well as a regular lecturer and organizer of national and international immunohistochemical workshops, particularly in the field of protocol optimization. He has published more than 20 scientific papers based on immunohistochemical studies.

Organizing/Scientific Committee:

Jan Klos MD Course Director
Members: prof. Janusz Rys and Dr. Krzysztof Okon


12th October Monday 10.00 – 18.00                                                   

09.00 – 10.00 Registration and coffee
10.00 – 10.05 Introduction (J. Klos)
10.05 – 11.20 Immunohistochemical principles – technical pitfalls (S. Nielsen)
11.20 – 11.40 Coffee break
11.40 – 13.00 Approach to unknown primary tumor (M. Vyberg)
13.00 – 14.00 Lunch
14.00 – 14.30 Diagnostic pitfalls in immunohistochemistry (J. Klos)
14.30 – 15.15 The role of immunohistochemistry in the era of targeted therapy (M. Miettinen)
15.15 – 16.00 Immunohistochemical versus molecular testing for targeted therapy: pros and cons (J. Lasota)
16.00 – 16.30 Coffee break
16.30 – 17.00 EQA in immunohistochemistry (M. Vyberg)
17.00 – 18.00 Presentation of seminar cases (Cases 7, 4 and 6)
19.15  22.00 Course Dinner with “surprize” at Impresja Restaurant, at Holiday Inn Hotel located at ul. Wielopole 4.

13th October Tuesday 09.00 – 16.45

09.00 – 10.00 Immunohistochemistry in the diagnosis of soft tissue tumors (M. Miettinen)
10.00 – 11.00 Relevance of molecular genetic testing for the diagnosis and classification of soft tissue tumors (J. Lasota)
11.00 – 11.30 Coffee break
11.30 – 12.15 Immunohistochemical markers in lung tumors and mesothelioma (M. Vyberg)
12.15 – 13.00 Immunohistochemistry of urinary tract with focus on the prostate (L. Egevad)
13.00 – 14.00 Lunch
14.00 – 15.00 Immunohistochemical markers in pathology of the breast (J. Klos)
15.00 – 15.30 Presentation of Seminar Cases (Case 1 and 5)
15.30 – 15.55 Coffee break
15.55 – 16.25 Presentation of Seminar Cases (Cases 3 and 2)
16.25 – 16.45 Summary + Evaluation (J. Klos)

Good clones/recommended protocols (1-2 slides!) included in the main lectures. Lecture time includes a free option for lecturer for 5 min for questions/discussion.